Active
Intoxicating hemp federal regulation
Bob Hoban, Hoban Law Group · Last updated May 2026
On-record soundbite (1–2 sentences)
“The 2018 Farm Bill created a regulatory gap that the FDA was never resourced to close. Intoxicating hemp derivatives now occupy a legal gray zone that will not survive the next farm bill reauthorization — operators who have built businesses on that gray zone need contingency plans now.”
— Robert Hoban, Hoban Law Group
Extended quote (3–4 sentences)
“The 2018 Farm Bill created a regulatory gap that the FDA was never resourced to close. Intoxicating hemp derivatives now occupy a legal gray zone that will not survive the next farm bill reauthorization — operators who have built businesses on that gray zone need contingency plans now. My view is that the most durable hemp businesses are those anchored to non-intoxicating functional ingredients with demonstrated FDA tolerance: CBD isolate, CBG, CBN. The synthetic cannabinoid space is a ticking enforcement clock.”
— Robert Hoban, Hoban Law Group
Attribution
Robert Hoban, Founder and Managing Partner, Hoban Law Group. Quotes may be used in editorial coverage with this attribution line. For background briefings or custom quotes on adjacent topics, contact the press team.
Related Resources
Press Quote
FDA cannabinoid regulation
The FDA's failure to establish a regulatory pathway for CBD as a dietary supplement after five ye…
Press QuoteDelta-8 THC and intoxicating hemp bans
States banning delta-8 without corresponding hemp program reform are creating regulatory arbitrag…
Press QuoteUSDA hemp program and 2018 Farm Bill
The USDA hemp program established compliance infrastructure — testing protocols, sampling require…